Specific biomarker test for early sepsis identification

EKF Diagnostics has introduced the Stanbio Chemistry Procalcitonin (PCT) LiquiColor Assay. This new test enables the quantitative determination of PCT in serum samples, EDTA or lithium heparin plasma samples by latex enhanced immunoturbidimetric methodology.

Procalcitonin is a marker for bacterial infection and sepsis and has been recognised as an important adjunct marker in the diagnosis of sepsis*.

The new Stanbio Chemistry Procalcitonin (PCT) LiquiColor Assay provides a precise result, which correlates well with established methodology, within 10 minutes and requires just 20µL of sample. The reagents may be used on almost any liquid-based chemistry analyser with open-channel capability. In addition, the reagent kit, calibrator and control sets are all available separately.

Commenting on the cost-effectiveness and convenience of the Stanbio Chemistry Procalcitonin (PCT) LiquiColor Assay, Al Blanco, Business Unit Director – Central Laboratory at EKF Diagnostics said: “This assay can be performed on a customer’s existing chemistry analyser with the same collection tube used for analysis of other chemistry tests. Therefore, it will provide optimised lab workflow by eliminating the need to split a sample or have a dedicated off-line workstation. These features will provide any lab with a cost-effective solution for PCT testing.”

* References: 1. Müller B, et al., Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001; 86(1):396-404; 2. Meisner M. Procalcitonin (PCT) – A new, innovative infection parameter. Biochemical and clinical aspects. Thieme; Stuttgart, New York, 2000; ISBN 3-13-105503-0; 3. Christ-Crain M, et al., Procalcitonin in bacterial infections – hype, hope or more or less? Swiss Med Wkly 2005; 135: 451-60.

Recent Issues